US Patent No. 8,889,644

GNAQ-targeted dsRNA compositions and methods for inhibiting expression
Nov 21, 2014

Alnylam Pharmaceuticals has been awarded US Patent No. 8,889,644, "GNAQ-targeted dsRNA compositions and methods for inhibiting expression."

Jared Gollob, Greg Hinkle, Ivanka Toudjarska, and David Bumcrot are named as the inventors.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.